Combined drug-radiation treatment: biological basis, current applications and perspectives 2019

Combined drug-radiation treatment: biological basis, current applications and perspectives is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Jun 07 - 09, 2019 at Severance Hospital, Seoul, South Korea.

Target Audience:
The course is aimed at radiation oncologists and medical oncologists involved in the multidisciplinary treatment of cancer.

Course Aim:
Effective cancer treatment necessitates both high efficacy of local treatment and combatting sub-clinical systemic disease. Consequently, cancer therapy today involves various combinations of local and systemic treatment modalities. Of those, combining drugs and radiation has been attracting particular attention both in terms of its biological rationale and its potential of increasing the therapeutic outcome. The course aims at updating participants about established and emerging knowledge in this field. It will provide the key-messages that biological and clinical research is currently bringing to the oncology community.

This course aims to:
• Update participants about biological effects of combining drugs and radiation in normal and tumour tissue
• Present evidence-based clinical applications of combined modality treatment using drugs and radiation in major human malignancies
• Stimulate case-based discussion on the interdisciplinary treatment of cancer
• Present future perspectives for combining drugs and radiation.

Learning Outcomes:
By the End of This Course Participants Should Be Able to:

• Describe the Rationale and Mechanisms of the Action of Combined Drug Radiation Treat­ment in Cancer
• Discuss the Evidence for Combined Drug Ra­diation Treatment in Different Tumour Sites
• Select Patients for Combined Drug Radiation Treatment
• Decide on the Optimum Treatment Strategy, Sequencing and Duration, for Different Patients
• Decide on the Optimum Strategy Including New Drugs (Immunotherapy Etc.).

Course Content:
General Lectures
• Describe the Rationale and Mechanisms of the Action of Combined Drug Radiation Treatment in Cancer
• Immunotherapy and Personalised Cancer Therapy
• Rationale for Altered Fractionation and Combining Radiation With Systematic Therapies
• Hypoxia: the Point of View of Biologist and Radiation Oncologist
• Immunotherapy and Radiotherapy
• Decision Making
• Endpoints in Oncology
• Radiotherapy and New Drugs: What Is Known and What Is Not
• Site Specific Lectures Including Practical Case Discussions
? Head and Neck Cancer
? Non Small Cell Lung Cancer
? Small Cell Lung Cancer
? Breast Cancer
? Prostate Cancer
? Bladder Cancer
? Cervical Cancer
? Oesophageal Cancer
? Gastric Cancer
? Rectal CancerAnal Canal
? Pancreas
? Brain Tumours
? Lymphomas.

Prerequisites:
Before Commencing This Course Participants Should:
• Be Confident With the Basic Mechanisms of Radiotherapy and Systemic Treatment in Oncology
•  Know the Basic Principles of Management of Solid Tumours
• Know Different Ways of Delivering Chemotherapy/systemic Therapy in Combination With Radiotherapy.

Additional details will be posted as soon as they are available.